Profil PT Combiphar

Profil Perusahaan / Lembaga - PT. Combiphar
Deskripsi Perusahaan / Kelembagaan

Berdiri pada tahun 1971, PT. Combiphar adalah perusahaan manufaktur dan distribusi untuk produk farmasi dengan kantor pusat berlokasi di area Kecamatan Cilandak Kota Jakarta Selatan Provinsi Daerah Khusus Ibukota Jakarta. PT. Combiphar memproduksi dan memasarkan lebih dari 200 produk obat resep dan bebas (over-the-counter) berkualitas tinggi, termasuk produk ikonik seperti OBH Combi dan Insto.

Didukung dengan fasilitas pabrik yang berlokasi di wilayah Kecamatan Padalarang Kabupaten Bandung Barat Provinsi Jawa Barat, Combiphar berkomitmen menyediakan produk terjangkau dan berkualitas untuk masyarakat Indonesia. Combiphar juga telah mengekspor produknya ke Australia karena telah mendapatkan sertifikasi Therapeutic Goods Administration (TGA) Australia.

Combiphar was founded in 1971 as a pharmaceutical company. Today, Combiphar is transforming into a modern consumer healthcare company that produces and markets more than 200 prescription and over-the-counter quality and affordable products, among others, OBH Combi cough syrup, Insto eye-care solution, JointFit gel-based relief for joints, CombiKid vitamin supplements, Privé green-tea based feminine hygiene wash, and Hezandra hepatoprotector supplement.

Equipped with the latest production technology and the most up-to-date professional operation standards, Combiphar’s manufacturing plant, which is located in Padalarang, West Java, has most recently obtained the Therapeutic Goods Administration (TGA) Certification, allowing selected products to be exported to Australia.

Additionally, Combiphar also has its own Research & Development facility, focusing on the quality optimization of prescription drugs to ensure that they meet the requirements of Bioavailability and Bioequivalence, as well as in the field of Nanotechnology.

Combiphar has recently been ranked 2nd among local pharmaceutical companies recognized as “Indonesia’s Most Reputable Healthcare Brands 2015” (Onbee Research/SWA, May 2015) in terms of brand equity, customer loyalty, and customer experience.